Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Ly6g6e (lymphocyte antigen 6 family member G6E) Rattus norvegicus
Analyze
Symbol: Ly6g6e
Name: lymphocyte antigen 6 family member G6E
Description: Predicted to have acetylcholine receptor activator activity and acetylcholine receptor binding activity. Predicted to be involved in acetylcholine receptor signaling pathway and desensitization of G protein-coupled receptor signaling pathway. Predicted to localize to plasma membrane. Orthologous to human LY6G6E (lymphocyte antigen 6 family member G6E); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; bisphenol A.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: lymphocyte antigen 6 complex G6E; lymphocyte antigen 6 complex, locus G6E
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0205,063,148 - 5,069,032 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl205,067,330 - 5,068,624 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0207,137,208 - 7,141,962 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4203,808,707 - 3,810,443 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.1203,808,933 - 3,810,670 (-)NCBI
Celera204,279,251 - 4,280,984 (+)NCBICelera
Cytogenetic Map20p12NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Expression

RNA-SEQ Expression

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 6.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Ly6g6e
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1303112
Created: 2004-12-03
Species: Rattus norvegicus
Last Modified: 2020-08-20
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.